These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 918061)
1. Hypernephroma--natural history and the influence of immunotherapy. deKernion JB Proc Inst Med Chic; 1977; 31(5):153. PubMed ID: 918061 [No Abstract] [Full Text] [Related]
2. [Palliative treatment of metastasized hypernephroma]. Klippel KF; Altwein JE Dtsch Med Wochenschr; 1979 Jan; 104(1):28-31. PubMed ID: 83228 [No Abstract] [Full Text] [Related]
3. BCG immunotherapy of metastatic adenocarcinoma of the kidney. Eidinger D; Morales A Natl Cancer Inst Monogr; 1978 Dec; (49):339-41. PubMed ID: 748790 [No Abstract] [Full Text] [Related]
7. [Treatment of advanced kidney adenocarcinoma]. Fosså S; Urianstad MK; Talle K Tidsskr Nor Laegeforen; 1975 May; 95(13):806-9. PubMed ID: 1135804 [No Abstract] [Full Text] [Related]
8. Current status of immunotherapy in stage IV renal adenocarcinoma. Klotz SD; Sweeney MJ J Fla Med Assoc; 1983 Jan; 70(1):39-42. PubMed ID: 6827244 [No Abstract] [Full Text] [Related]
9. [Treatment of disseminated renal adenocarcinoma. Review of the literature]. Escudero Barrilero A Arch Esp Urol; 1987 Mar; 40(2):79-86. PubMed ID: 3296965 [No Abstract] [Full Text] [Related]
11. Management of renal carcinoma. Whitehead ED N Y State J Med; 1981 May; 81(6):911-4. PubMed ID: 6785679 [No Abstract] [Full Text] [Related]
12. [Neoadjuvant immunotherapy in non-metastatic renal adenocarcinoma]. Sánchez de la Muela P; Zudaire Bergera JJ; Robles García JE; Isa Kroon W; de Castro Barbosa F; Aguera Fernández L; Rosell Costa D; Berián Polo JM Actas Urol Esp; 1990; 14(6):396-400. PubMed ID: 2080725 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of metastasizing renal adenocarcinoma with specific plasma transfusion. A controlled trial of the effects on metastases and survival time]. Pedersen F; Hippe E; Hvidt V; Francis D; Jensen HS; Dybkjaer E; Rasmussen F Ugeskr Laeger; 1980 Nov; 142(48):3167-70. PubMed ID: 7003883 [No Abstract] [Full Text] [Related]
14. Disappearance of lung metastases during immunotherapy in five patients suffering from renal carcinoma. Tykkä H; Hjelt L; Oravisto KJ; Turunen M; Tallberg T Scand J Respir Dis Suppl; 1974; 89():123-34. PubMed ID: 4528514 [No Abstract] [Full Text] [Related]
15. [5 years' experience in the immunotherapy of human cancer]. Humphrey LJ; Boehm OR; Boehm BJ; Jewell WR Zentralbl Chir; 1973 Sep; 98(35):1241-6. PubMed ID: 4784998 [No Abstract] [Full Text] [Related]
16. Interferon and doxorubicin in renal cell carcinoma. Muss HB; Welander C; Caponera M; Reavis K; Cruz JM; Cooper MR; Jackson DV; Richards F; Stuart JJ; Spurr CL Cancer Treat Rep; 1985 Jun; 69(6):721-2. PubMed ID: 4016777 [No Abstract] [Full Text] [Related]
18. [Metastasis of a hypernephroma to the thyroid gland (2 cases)]. Rozanov IuL; Nabakov ShA Vopr Onkol; 1967; 13(2):82-3. PubMed ID: 5599259 [No Abstract] [Full Text] [Related]
19. Current concepts in the management of renal adenocarcinoma. Catalona WJ Mo Med; 1980 Jan; 77(1):19-23, 26. PubMed ID: 6986549 [No Abstract] [Full Text] [Related]
20. Adjunctive treatment of renal cell carcinoma. Pontes JE Int Adv Surg Oncol; 1983; 6():309-22. PubMed ID: 6874085 [No Abstract] [Full Text] [Related] [Next] [New Search]